CLOVER HEALTH INVTS A (CLOV) is drawing unusual attention today. Our newswire has captured 1 story on CLOV across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
CLOV stock surged 21.06% to $5.02 in Monday trading, driven by a combination of strong earnings results and an upward revision to full-year revenue guidance. The company reported GAAP earnings per share of $0.05, exceeding estimates by $0.02, and revenue of $743.17 million, which beat expectations by $14.9 million. Clover also raised its FY 2026 revenue guidance to a range of $2.92 billion to $3.0 billion, reflecting confidence in its AI-driven Medicare Advantage growth strategy.
Clover Health released its Q2 2026 earnings results on August 5, with the stock opening at $4.55, a 9.9% gap up from the previous close. The company’s earnings call highlighted its 4.5-Star rating, which provides flexibility for 2027, and outlined continued momentum in its MA business. The SEC 8-K filing confirmed the results and guidance update, while the slide deck and transcript from the earnings call provided further details on operational performance. The stock’s sharp intraday rally pushed it to a session high of $5.19, with the last trade at $4.99.
The stock’s 52-week range is $1.58 to $5.59, and the current price is near the upper end of that range. Year-to-date revenue has grown by 48.7%, but the company remains unprofitable with a TTM net margin of -2.6%. The session’s volume of 1.0 million shares is 0.1x the 3-month daily average, suggesting limited retail or institutional participation. Over the last 8 sessions, the stock had fallen 3.0% from $4.27 to $4.14 before Monday’s reversal. Insider transactions in the last 90 days totaled 18 sales worth $4.1 million, with the most recent on July 20.
The stock is currently priced at $4.99, and investors should monitor the company’s ability to maintain its guidance and improve profitability. No earnings date is scheduled in the near term, but coverage breadth and any follow-up commentary from analysts will be key to the stock’s near-term direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Clover Health Investments Corp (($CLOV)) has held its Q2 earnings call. Read on for the main highlights of the call. Clover Health Investments Corp struck an upbeat...
CLOVER HEALTH INVTS A (CLOV) is drawing unusual attention today. Our newswire has captured 1 story on CLOV across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 63/100). The most recent driver: "Clover Health Earnings Call Signals Profitable Growth" (TipRanks).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of CLOV coverage reads 63/100 over 1 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on CLOV: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CLOV move explainers: 2026-08-06